Morphine enhances macrophage apoptosis

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1886-1893

  Singhal, Pravin C ^a   Sharma, Puneet ^b   Kapasi, Aditi A ^b   Reddy, Krishna ^b   Franki, Nicholas ^b   Gibbons, Nora ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CD14 ANTIGEN; DNA FRAGMENT; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MESSENGER RNA; MORPHINE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NALTREXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIATE AGONIST; OPIATE ANTAGONIST; PROTEIN P53;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MONOCYTE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; HUMANS; MACROPHAGES; MALE; MORPHINE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032519904     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Briggs, J. H., C. G. McKerron, R. L. Souhami, D. J. E. Taylor, and H. Andrews. 1967. Severe systemic infections complicating "mainline" heroin addiction. Lancet 2:1227.
2. Hussey, H. H., and S. Katz. 1945. Septic pulmonary infarction: report of eight cases. Ann. Intern. Med. 22:526.
3. Luttgens, W. F. 1949. Endocarditis in "main line" opium addicts. Arch. Intern. Med. 83:653.
4. Olsson, R. A., and M. J. Romansky. 1962. Staphylococcus tricuspid endocarditis in heroin addicts. Ann. Intern. Med. 57:755.
5. Bayer, B. M., and C. M. Flores. 1990. Effects of morphine on lymphocytic function. In Drugs of Abuse and Immune Function. R. R. Watson, ed. CRC Press, Baton Rouge, LA, p. 151.
6. Peterson, P. K., B. Sharp, G. Gekker, C. Brummitt, and W. F. Keane. 1987. Opioid-mediated suppression of interferon gamma production by cultured peripheral blood mononuclear cells. J. Clin. Invest. 80:824.
7. Bussiere, J. L., D. D. Taub, J. J. Meissler, M. W. Adler, T. J. Rogers, and T. K. Eisenstein. 1993. Effects of opioids on murine antibody responses. In Alcohol, Drugs of Abuse and Immunomodulation. R. R. Watson, ed. Pergamon Press, New York, p. 563.
8. Casellas, A. M., H. Guardiola, and F. L. Renand. 1991. Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides 18:35.
9. Peterson, P. K., B. Sharp, G. Gekker, C. Brummit, and W. F. Keane. 1987. Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J. Immunol. 138:3907.
10. Hoidal, J. R., D. Schmeling, and P. K. Peterson. 1981. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J. Infect. Dis. 144:61.
11. Nathan, C. F., H. W. Murray, and Z. A. Cohn. 1982. The macrophage as an effector cell. N. Engl. J. Med. 303:622.
12. Tubaro, E., G. Borelli, C. Croce, G. Cavalio, and C. Santiangeli. 1983. Effect of morphine on resistance to infection. J. Infect. Dis. 148:656.
13. Singhal, P. C., C. Pan, and N. Gibbons. 1993. Effect of morphine on uptake of immunoglobulin G complexes by mesangial cells and macrophages. Am. J. Physiol. 264:F859.
14. Singhal, P. C., C. Q. Pan, N. Gibbons, and E. Valderrama. 1993. Effect of morphine on immunoglobulin G aggregate kinetics. Am. J. Physiol. 265:C1211.
15. Meßmer, U. K., J. C. Reed, and B. Brune. 1996. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem. 271:20192.
16. Sharma, S., R. T. Sankaran, Z. Shan, N. Gibbons, and P. C. Singhal. 1996. Escherichia coli-macrophage interactions modulate mesangial cell proliferation and matrix synthesis. Nephron 73:587.
17. Singhal, P. C., P. Sharma, K. Reddy, V. Sanwal, J. Rawal, N. Gibbons, and N. Franki. 1997. HIV-1 gp160 protein modulates proliferation and apoptosis in mesangial cells. Nephron 76:284.
18. Trachtman, H., S. Futterweit, P. Garg, K. Reddy, and P. C. Singhal. 1996. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 218:704.
19. Mattana, J., and P. C. Singhal. 1994. L-arginine supplementation antagonizes the effects of angiotensin II and endothelin 1 on mesangial cell proliferation. Cell. Physiol. Biochem. 5:176.
20. Trachtman, H., S. Futterweit, R. Greenwald, S. Moak, P. C. Singhal, N. Franki, A. R. Amin. 1996. Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 229:243.
21. Sharma, P., K. Reddy, N. Franki, V. Sanwal, R. Sankaran, T. Ahuja, N. Gibbons, J. Mattana, and P. C. Singhal. 1996. Native and oxidized low density lipoproteins modulate mesangial cell apoptosis. Kidney Int. 50:1604.
22. Miura, M., H. Zhu, R. Rotello, E. A. Hartwig, and Y. Yan. 1993. Induction of apoptosis in fibroblasts by IL-1-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75::653.
23. Canman, C., T. A. Gilmer, S. B. Coutts, and M. B. Kastan. 1995. Growth factor modulation of p53-mediated growth arrest vs. apoptosis. Genes Dev. 9:600.
24. Clark, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849.
25. Raff, M. R. 1992. Social control on cell survival and cell death. Nature 356:397.
26. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of the disease. Science 267:1456.
27. Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1.
28. Yang, E., and S. J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 88:386.
29. Lopker, A., L. G. Abood, W. Hoss, and F. J. Lionetti. 1980. Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem. Pharmacol. 29:1361.
30. Stefano, G. B., A. Digenis, S. Spector, M. K. Leung, T. Bilfinger, M. H. Makman, B. Scharrer, and N. N. Abmurad. 1993. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Natl. Acad. Sci. USA 90:11099.
31. 3-opiate receptors. Eur. J. Pharmacol. 273:R5.
32. Smith, M. L., and A. J. Fornace, Jr. 1996. Two faces of tumor suppressor p53. Am. J. Pathol. 148:1019.
33. Wybran, J., T. Appelboom, J. P. Famaey, and A. Govaerts. 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol. 123:1068.
34. Ovadia, H., P. Nitsan, and O. Abramsky. 1989. Characterization of opiate binding sites on membranes of rat lymphocytes. J. Neuroimmunol. 21:93.
35. Bryant, H. U., E. W. Bernton, J. R. Kenner, and J. W. Holaday. 1991. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology 128:3253.
36. Weigent, D. A., and J. E. Blalock. 1987. Interactions between the neuroendocrine and immune systems: common hormone and receptors. Immunol. Rev. 100:79.